e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Emerging occupational and environmental lung hazards: from asthma to interstitial disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Auto-immune complications in pneumoconiois: an underappreciated comorbidity
Benjamin Fox (Petach Tikva, Israel)
Source:
International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease
Session:
Emerging occupational and environmental lung hazards: from asthma to interstitial disease
Session type:
Symposium
Number:
1719
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Benjamin Fox (Petach Tikva, Israel). Auto-immune complications in pneumoconiois: an underappreciated comorbidity. International Congress 2015 – Emerging occupational and environmental lung hazards: from asthma to interstitial disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Iatrogenic pneumothorax: aetiology and morbidity
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001
Noninfectious complications
Source: Eur Respir Mon; 2009: 45: 177–193
Year: 2009
Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Comorbidity and some issues of cardiovascular disorders in disabled asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Pregnancy complications and respiratory problems in childhood
Source: International Congress 2015 – Risk factors and early origins of respiratory diseases
Year: 2015
Mortality: a neglected outcome in OCS-treated severe asthma
Source: Eur Respir J, 50 (5) 1701486; 10.1183/13993003.01486-2017
Year: 2017
Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J , 49 (2) 1602522; DOI: 10.1183/13993003.02522-2016
Year: 2017
Comorbidity: a distinctive feature of elderly respiratory patients
Source: Eur Respir Mon; 2009: 43: 205–216
Year: 2009
Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Source: Eur Respir J, 53 (5) 1900418; 10.1183/13993003.00418-2019
Year: 2019
Severe asthma: one disease many definitions
Source: International Congress 2019 – Asthma and the world
Year: 2019
Bronchiectasis as a serious problem in children: ethiology, diagnosis and symptoms
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Neutrophilia is not associated with complications during hospitalisation
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007
Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Cardiovascular complications and comorbidities in CAP
Source: Eur Respir Monogr 2014; 63: 256-254
Year: 2014
Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Systemic inflammation, comorbidities and the outcome of adult-onset asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Hemorrhagic complications in patients with COVID-19. Are they unusual?
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Anaemia in COPD: mortality and disease severity
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept